Application of mass spectrometry for the diagnosis and monitoring of real life patients with monoclonal gammopathies

Basic Information

Funding Cycle : 2021-2022
Name : Noemi Puig
Type of Award : Translational Research Award
Home Institution : Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León, Spain


The research plan aims to assess the utility of mass spectrometry (MS) for diagnosing and monitoring patients with multiple myeloma (MM), amyloidosis (AL), and Waldenström’s macroglobulinemia (WM). Specific aims include comparing MS with standard methods like serum protein electrophoresis (SPEP) and immunofixation (IFE) for identifying and quantifying monoclonal proteins, evaluating MS’s ability to detect minimal residual disease (MRD), distinguishing therapeutic antibodies from endogenous monoclonal proteins, and examining post-translational modifications in M-proteins. Disease-specific objectives involve investigating oligosecretory and non-secretory MM cases, quantifying IgM M-proteins in WM, and analyzing AL cases lacking organic response despite reaching complete remission. The study aims to enhance diagnostic accuracy, refine treatment monitoring, and potentially enable broader patient inclusion in clinical trials.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events